Reardon Andrew

CLO & SecretaryLIGAND PHARMACEUTICALS INC (LGND) · full profile →Form 4 · filed Jul 6, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$1.6M
Net Open-Market Flow
-$1.6M
Transactions
11
10 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 1, 2026Sell(S)600$317.15$190K42K
Jul 1, 2026Option exercise(M)5K$52.27$261K47K
Jul 1, 2026Sell(S)396$308.99$122K46K
Jul 1, 2026Sell(S)104$310.20$32K46K
Jul 1, 2026Sell(S)1K$311.72$349K45K
Jul 1, 2026Sell(S)1K$312.28$338K44K
Jul 1, 2026Sell(S)700$313.46$219K43K
Jul 1, 2026Sell(S)100$314.58$31K43K
Jul 1, 2026Sell(S)900$315.78$284K42K
Jun 30, 2026Other(J)132$160.71$21K42K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jul 1, 2026Option exercise(M)5K$034K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion
J
Other acquisition / disposition

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0002001011-26-000108) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

Build

Ask your agent about LGND insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0002001011-26-000108"
Ask your agent
Use Arkolith to summarize insider buying and selling at LIGAND PHARMACEUTICALS INC
over the last 90 days and cite the filings.